Does DABRAFENIB Cause Blood creatine phosphokinase increased? 238 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 238 reports of Blood creatine phosphokinase increased have been filed in association with DABRAFENIB (Tafinlar). This represents 1.2% of all adverse event reports for DABRAFENIB.
238
Reports of Blood creatine phosphokinase increased with DABRAFENIB
1.2%
of all DABRAFENIB reports
26
Deaths
120
Hospitalizations
How Dangerous Is Blood creatine phosphokinase increased From DABRAFENIB?
Of the 238 reports, 26 (10.9%) resulted in death, 120 (50.4%) required hospitalization, and 12 (5.0%) were considered life-threatening.
Is Blood creatine phosphokinase increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 238 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Blood creatine phosphokinase increased?
ATORVASTATIN (1,491)
SIMVASTATIN (895)
ROSUVASTATIN (859)
QUETIAPINE (663)
CLOZAPINE (610)
ARIPIPRAZOLE (594)
OLANZAPINE (561)
DAPTOMYCIN (461)
RISPERIDONE (402)
EZETIMIBE (350)
Which DABRAFENIB Alternatives Have Lower Blood creatine phosphokinase increased Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB